News
0
China’s food and drug regulator recently carried out a one year long review of clinical trials and the resultant data, finding that the 80% of data...
0
The drug has received a final recommendation from NICE for the treatment of visual impairment due to macular oedema secondary to branch retinal vein...
0
The London-based company has released more positive data from a Phase III trial for Epidiolex. The experimental cannabidiol drug has been used to...
0
According to research and consulting firm GlobalData, the Malaysian market is projected to go from $2.3 billion in 2015 to $3.6 billion by 2020 with...
Features
Paul Ranson, of global law firm Morgan Lewis' London Life Sciences Practice examines how UK biopharma must now adapt to a changing landscape
Featured Appointment
German pharma firm Merck has appointed Isabel De Paoli to the position of chief science officer in addition to her current position as...
Service Company News
Featured Event
04/10/2016 - 06/10/2016 -
Barcelona,
@Pharmafocus
